Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Authors
Keywords
-
Journal
Vaccines
Volume 11, Issue 2, Pages 394
Publisher
MDPI AG
Online
2023-02-09
DOI
10.3390/vaccines11020394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
- (2022) Monika Semmrich et al. Journal for ImmunoTherapy of Cancer
- Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
- (2022) Jiahui Zhang et al. International Journal of Nanomedicine
- Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
- (2022) Yan Tie et al. Journal of Hematology & Oncology
- Surgical Tumor-Derived Photothermal Nanovaccine for Personalized Cancer Therapy and Prevention
- (2022) Tan Li et al. NANO LETTERS
- The clinical progress of mRNA vaccines and immunotherapies
- (2022) Ann J. Barbier et al. NATURE BIOTECHNOLOGY
- Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
- (2022) Zhilin Li et al. Advanced Science
- Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine
- (2022) Jingyi Xia et al. BIOMEDICINE & PHARMACOTHERAPY
- Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
- (2022) Raquel S Laureano et al. OncoImmunology
- Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
- (2022) Fei Ju et al. Journal for ImmunoTherapy of Cancer
- In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors
- (2022) Deqiu Huang et al. BIOMATERIALS
- Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
- (2022) Arshpreet Kaur et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
- (2022) Cathrine Lund Lorentzen et al. LANCET ONCOLOGY
- Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy
- (2022) Xiaoxue Xie et al. Bioactive Materials
- Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting
- (2022) Harun Achmad et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
- (2022) Jing Zhou et al. Cancer Medicine
- Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects
- (2022) Madhu Gupta et al. Vaccines
- Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC
- (2022) Chenxin Li et al. Pharmaceuticals
- CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy
- (2022) Shengyang Liu et al. Bioactive Materials
- A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody
- (2022) Zhilin Li et al. Bioactive Materials
- The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
- (2021) Ravi Jhaveri CLINICAL THERAPEUTICS
- Dendritic cells: The first step
- (2021) Gwendalyn J. Randolph JOURNAL OF EXPERIMENTAL MEDICINE
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
- (2021) Zimei Wu et al. PHARMACEUTICAL RESEARCH
- Characterization of a recombinant gorilla-adenovirus HPV therapeutic vaccine (PRGN-2009)
- (2021) Samuel T. Pellom et al. JCI Insight
- Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
- (2021) Yalei Zhang et al. Cancer Cell International
- Peptide‐based therapeutic cancer vaccine: Current trends in clinical application
- (2021) Wensi Liu et al. CELL PROLIFERATION
- Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
- (2021) Pier Francesco Ferrucci et al. Cancers
- Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis
- (2021) Shichuan Hu et al. Acta Biomaterialia
- A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine
- (2021) Wei Shi et al. CANCER LETTERS
- Methods to improve the immunogenicity of plasmid DNA vaccines
- (2021) Dalinda Eusébio et al. DRUG DISCOVERY TODAY
- Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
- (2021) Chang-Gon Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-assembled Nanocomplexes of Peptide Neoantigen Adpgk and Toll-like Receptor 9 Agonist CpG ODN for Efficient Colorectal Cancer Immunotherapy
- (2021) Zhaoyuan Liang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA
- (2021) Yi-Pin Chen et al. Taiwanese Journal of Obstetrics & Gynecology
- From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
- (2021) Chiranjib Chakraborty et al. Frontiers in Immunology
- Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
- (2021) Jiachen Li et al. ADVANCED MATERIALS
- mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
- (2021) Maryam Bidram et al. Vaccines
- Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy
- (2021) Jie Chen et al. Bioactive Materials
- Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
- (2020) Shinsuke Nakao et al. Science Translational Medicine
- Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
- (2020) Alexey V. Baldin et al. Cancers
- Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger
- (2020) Yingying Hu et al. BIOMATERIALS
- mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
- (2020) Shuqin Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
- (2020) Rana Mhaidly et al. SEMINARS IN IMMUNOLOGY
- TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
- (2020) Yuki Tanaka et al. Scientific Reports
- HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals
- (2020) Dieter Glebe et al. ANTIVIRAL RESEARCH
- Hepatitis B Vaccines
- (2020) Jade Pattyn et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine-induced memory CD8+ T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study
- (2019) Erika J Crosby et al. CLINICAL CANCER RESEARCH
- Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
- (2019) Zong Sheng Guo et al. Journal for ImmunoTherapy of Cancer
- Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
- (2019) Shweta Joshi et al. Journal of Oncology
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
- (2019) Ashish C. Shrestha et al. Vaccines
- Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
- (2019) Renjie Wang et al. CANCER LETTERS
- Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
- (2019) Jia Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
- (2018) Catherine E Handy et al. Future Oncology
- Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
- (2018) Chunmei Fu et al. Frontiers in Immunology
- Dendritic cell-based immunotherapy: a basic review and recent advances
- (2017) João Constantino et al. IMMUNOLOGIC RESEARCH
- Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
- (2016) Praveen K. Bommareddy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion
- (2016) Yosuke Kano et al. CANCER SCIENCE
- Immunotherapy against cancer-related viruses
- (2016) Haruko Tashiro et al. CELL RESEARCH
- DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
- (2016) Angeliki Tiptiri-Kourpeti et al. PHARMACOLOGY & THERAPEUTICS
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
- (2016) S.H.T. Jorritsma et al. VACCINE
- Peptide-based synthetic vaccines
- (2016) Mariusz Skwarczynski et al. Chemical Science
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
- (2016) Jon Amund Kyte et al. OncoImmunology
- Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
- (2015) Yasuhiko Ohshio et al. CANCER SCIENCE
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
- (2015) Rachid Ammi et al. PHARMACOLOGY & THERAPEUTICS
- A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development
- (2015) Oana Draghiciu et al. OncoImmunology
- Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
- (2015) Kalijn F Bol et al. OncoImmunology
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma
- (2014) G. T. Gibney et al. CLINICAL CANCER RESEARCH
- Development and Function of Dendritic Cell Subsets
- (2014) Alexander Mildner et al. IMMUNITY
- Composite peptide-based vaccines for cancer immunotherapy (Review)
- (2014) JIE YANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
- (2014) C. Maisonneuve et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic Cells in the Cancer Microenvironment
- (2013) Yang Ma et al. Journal of Cancer
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Directing dendritic cell immunotherapy towards successful cancer treatment
- (2009) Rachel Lubong Sabado et al. Immunotherapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now